SSE

Lookout Named a Strong Performer in 2022 Gartner® Peer Insights™ Voice of the Customer for Security Service Edge

Retrieved on: 
Tuesday, August 16, 2022 - 1:00pm

SAN FRANCISCO, Aug. 16, 2022 /PRNewswire/ -- Lookout, a leader in endpoint and cloud security solutions, today announced it has been named a "Strong Performer" in the Gartner® Peer Insights™ "Voice of the Customer" for Security Service Edge (SSE). Gartner Peer Insights is a reviews and ratings platform for technology end users to provide candid customer feedback and for technology decision makers to learn about a company's products and services. The "Voice of the Customer" is a document that synthesizes these user reviews into insights for IT decision makers.

Key Points: 
  • SAN FRANCISCO, Aug. 16, 2022 /PRNewswire/ -- Lookout , a leader in endpoint and cloud security solutions, today announced it has been named a "Strong Performer" in the Gartner Peer Insights "Voice of the Customer" for Security Service Edge (SSE).
  • The "Voice of the Customer" is a document that synthesizes these user reviews into insights for IT decision makers.
  • Capabilities include access control, threat protection, data security, security monitoring and acceptable use control enforced by network-based and API-based integration.
  • Lookout employees are deeply committed to meeting the needs and objectives of our customers, and we're honored to be recognized in the Gartner Peer Insights report."

BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care

Retrieved on: 
Monday, August 15, 2022 - 12:00pm

The partnership will be led by Ontada and focus on accelerating the development and implementation of RWE to improve community education on the financial impact and value of oncolytics as well as improve patient access to oncology medicines.

Key Points: 
  • The partnership will be led by Ontada and focus on accelerating the development and implementation of RWE to improve community education on the financial impact and value of oncolytics as well as improve patient access to oncology medicines.
  • Working together, BeiGene and Ontada will generate novel oncology insights through real-world data, tools, and technologies that will facilitate the acceleration of precise decision-making in support of community oncology practices whose ultimate mission is to improve patient outcomes.
  • As a leader in real-world research, Ontada is uniquely positioned to support complex research that uncovers deeper patient insights and perspectives that advance cancer care, said Susan Shiff, Ph.D., president of Ontada.
  • Novartis and BeiGene also entered into a strategic commercial agreement through which BeiGene will promote five approved Novartis Oncology products across designated regions of China.

Announcement of Intention to Delist American Depositary Shares from the New York Stock Exchange and Intention to Deregister and Terminate Reporting Obligations under the U.S. Securities Exchange Act

Retrieved on: 
Friday, August 12, 2022 - 10:07am

Such delisting is expected to become effective ten days after the filing of Form 25.

Key Points: 
  • Such delisting is expected to become effective ten days after the filing of Form 25.
  • The last trading day of ADSs on the NYSE will be on or about 1 September 2022.
  • Thereafter, the reporting obligations for the Company under the Exchange Act will be suspended unless Form 15F is subsequently revoked or rejected.
  • Private Securities Litigation Reform Act of 1995 and Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934.

SMIC Reports 2022 Second Quarter Results

Retrieved on: 
Thursday, August 11, 2022 - 2:03pm

SHANGHAI, Aug. 11, 2022 /PRNewswire/ -- Semiconductor Manufacturing International Corporation (SEHK: 00981; SSE STAR MARKET: 688981) ("SMIC", the "Company" or "we"), one of the leading semiconductor foundries in the world, today announced its consolidated results of operations for the three months ended June 30, 2022.

Key Points: 
  • SMIC Group provides semiconductor foundry and technology services to global customers on 0.35 micron to 14 nanometer process node technologies.
  • SMIC Group also has marketing and customer service offices in the U.S., Europe, Japan, and Taiwan, China, and a representative office in Hong Kong, China.
  • To supplement SMIC's consolidated financial results presented in accordance with IFRS, SMIC uses the presentation of non-IFRS financial measures, including EBITDA, EBITDA margin and non-IFRS operating expenses in this release.
  • SMIC believes that use of these non-IFRS financial measures facilitates investors' and management's comparisons to SMIC's historical performance.

Network Security Sales to Exceed $150 Billion Over the Next Five Years, According to Dell'Oro Group

Retrieved on: 
Thursday, August 11, 2022 - 1:00pm

REDWOOD CITY, Calif., August 11, 2022 /PRNewswire/ -- According to a recently published report from Dell'Oro Group, the trusted source for market information about the telecommunications, networks, and data center industries, demand for network security–which includes email security, firewall, security service edge (SSE), secure web gateway (SWG), and web application firewall (WAF) technologies–is expected to remain healthy over the next five years as solid enterprise investment in cloud applications and hybrid work drive the need for greater security and offset macro-economic headwinds.

Key Points: 
  • Additional highlights from Network Security July 2022 5-Year Forecast Report:
    SSE market revenue to experience a compounded annual growth rate (CAGR) of nearly 30 percent from 2021 to 2026.
  • Firewall market is expected to remain the largest network security segment by revenue and is forecasted to grow at an 8 percent CAGR over the forecast horizon.
  • Dell'Oro Group publishes the Network Security 5-year forecast report offering a complete overview of the industry with tables covering the same segments and metrics captured in our quarterly reports.
  • Dell'Oro Group is a market research firm that specializes in strategic competitive analysis in the telecommunications and enterprise networks, data center infrastructure, and network security markets.

Climb Channel Solutions Announces Partnership with Cato Networks

Retrieved on: 
Thursday, August 11, 2022 - 1:00pm

The partnership with Cato Networks will equip Climb Channel Solutions and its partners with such an approach.

Key Points: 
  • The partnership with Cato Networks will equip Climb Channel Solutions and its partners with such an approach.
  • Cato Networks is a channel-first SASE provider, said Ron Hamlett, Director of Channel Sales, Americas, at Cato Networks.
  • Climb Channel Solutions partners that join Catos channel ecosystem should expect to gain new revenue streams due to the convergence of network and security.
  • IT Security has become the most important product sector for Climb, but crowded with solutions, said Dale Foster, CEO of Climb Channel Solutions.

Netskope Honored in Forbes Cloud 100 for Sixth Year

Retrieved on: 
Tuesday, August 9, 2022 - 8:20pm

SANTA CLARA, Calif., Aug. 9, 2022 /PRNewswire/ -- Netskope, a leader in secure access service edge (SASE), today announced that for the sixth time, it has been named to the Forbes Cloud 100, the definitive ranking of the top 100 private cloud companies in the world, published by Forbes in partnership with Bessmer Venture Partners and Salesforce Ventures. In the 2022 Forbes Cloud 100, Netskope is ranked #30, and is just one of four listed security providers in the top 50.

Key Points: 
  • In the 2022 Forbes Cloud 100, Netskope is ranked #30, and is just one of four listed security providers in the top 50.
  • "We are honored to again be included in Forbes' listing of the world's most important cloud companies transforming the way business is done."
  • For the seventh straight year, the Cloud 100 reviewed submissions from hundreds of cloud startups and private companies.
  • "Despite the market correction in 2022, our confidence in the cloud economy continues to growtoday over 70% of the 2022 Cloud 100 Honorees have reached or exceeded $100 million in annual recurring revenue making them cloud Centaurs.

Skyhigh Security Named a 2022 Gartner® Peer Insights™ Customers’ Choice for Security Service Edge

Retrieved on: 
Tuesday, August 9, 2022 - 1:00pm

Skyhigh Security today announced it was named a Customers Choice in the Gartner Peer Insights Voice of the Customer: Security Service Edge report.

Key Points: 
  • Skyhigh Security today announced it was named a Customers Choice in the Gartner Peer Insights Voice of the Customer: Security Service Edge report.
  • Out of the 17 vendors assessed, Skyhigh Security received Customers Choice distinctions across all company size segments, the finance segment, and all deployment region segments, as defined by Gartner.
  • The Gartner Peer Insights Customers Choice is based on feedback and ratings from end-user professionals who purchase, implement and/or use the Skyhigh Security platform.
  • Gartner, Gartner Peer Insights Voice of the Customer: Security Service Edge, Peer Contributors, 3 August 2022
    Gartner, Magic Quadrant for Security Service Edge, John Watts, Craig Lawson, Charlie Winckless, Aaron McQuaid, 15 February 2022
    Gartner, Critical Capabilities for Security Service Edge, Craig Lawson, Charlie Winckless, John Watts, Aaron McQuaid, 16 February 2022

BeiGene Announces Positive Global Phase 3 Trial Results for PD-1 Inhibitor Tislelizumab in First-Line Unresectable Hepatocellular Cancer

Retrieved on: 
Tuesday, August 9, 2022 - 11:00am

The safety profile for tislelizumab was consistent with previous studies and no new safety signals were reported.

Key Points: 
  • The safety profile for tislelizumab was consistent with previous studies and no new safety signals were reported.
  • Patients with unresectable HCC face a devastating prognosis, with a median life expectancy of one year.
  • RATIONALE 301 (NCT03412773) is a global, Phase 3, randomized, open-label study of tislelizumab compared with sorafenib as a first-line treatment in adult patients with unresectable HCC.
  • The global tislelizumab clinical development program includes more than 11,000 subjects enrolled to-date in 30 countries and regions.

U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)

Retrieved on: 
Monday, August 8, 2022 - 7:10am

Darolutamide in combination with docetaxel and ADT demonstrated a 32.5% reduction in the risk of death compared to docetaxel plus ADT.

Key Points: 
  • Darolutamide in combination with docetaxel and ADT demonstrated a 32.5% reduction in the risk of death compared to docetaxel plus ADT.
  • The compound is also being investigated in further studies across various stages of prostate cancer.
  • Ng, K., Smith, S., Shamash, J. Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting.
  • Hahn AW, Higano CS, Taplin ME, Ryan CJ, Agarwal N. Metastatic Castration-Sensitive Prostate Cancer: Optimizing Patient Selection and Treatment.